{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:42:00Z","timestamp":1792618920621,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014-02048"],"award-info":[{"award-number":["2014-02048"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-02184"],"award-info":[{"award-number":["2016-02184"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014-07603"],"award-info":[{"award-number":["2014-07603"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003426","name":"G\u00f6ran Gustafssons Stiftelse f\u00f6r Naturvetenskaplig och Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00151","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T09:49:28Z","timestamp":1582278568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs"],"prefix":"10.3389","volume":"11","author":[{"given":"Alyson A.","family":"Fiorillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.13510","article-title":"Circulating microRNAs as potential biomarkers in myasthenia gravis patients","volume":"1412","author":"Punga","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","article-title":"Biomarker development for myasthenia gravis","volume":"1275","author":"Kaminski","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J Neurol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis","volume":"321","author":"Sabre","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/acn3.692","article-title":"miR-30e-5p as predictor of generalization in ocular myasthenia gravis","volume":"6","author":"Sabre","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.01.003","article-title":"Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis","volume":"292","author":"Punga","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","article-title":"Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy","volume":"60","author":"Monici","year":"2003","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12016-016-8549-4","article-title":"Review on toll-like receptor activation in myasthenia gravis: application to the development of new experimental models","volume":"52","author":"Robinet","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.13534","article-title":"Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?","volume":"1413","author":"Cavalcante","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.049","article-title":"Imbalance of circulating CD4+CXCR5+FOXP3+ Tfr-like cells and CD4+CXCR5+FOXP3- Tfh-like cells in myasthenia gravis","volume":"630","author":"Wen","year":"2016","journal-title":"Neurosci Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity."},{"key":"B18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.imlet.2004.10.007","article-title":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations","volume":"97","author":"Phiel","year":"2005","journal-title":"Immunol Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1152\/physiolgenomics.00134.2017","article-title":"Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone","volume":"50","author":"Fiorillo","year":"2018","journal-title":"Physiol Genomics."},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08916934.2018.1454913","article-title":"Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis","volume":"51","author":"Zhang","year":"2018","journal-title":"Autoimmunity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.2741\/3001","article-title":"Transcription factors in autoimmune diseases","volume":"13","author":"Peng","year":"2008","journal-title":"Front Biosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"D110","DOI":"10.1093\/nar\/gkv1176","article-title":"JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles","volume":"44","author":"Mathelier","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1101\/gr.8.3.319","article-title":"Identification of human gene core promoters in silico","volume":"8","author":"Zhang","year":"1998","journal-title":"Genome Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1000773","DOI":"10.1371\/journal.pcbi.1000773","article-title":"A quantitative model of transcriptional regulation reveals the influence of binding location on expression","volume":"6","author":"MacIsaac","year":"2010","journal-title":"PLoS Comput Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e201800186","DOI":"10.26508\/lsa.201800186","article-title":"Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy","volume":"2","author":"Heier","year":"2019","journal-title":"Life Sci Alliance"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","article-title":"Data normalization strategies for MicroRNA quantification","volume":"61","author":"Schwarzenbach","year":"2015","journal-title":"Clin Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2015.03.008","article-title":"Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity","volume":"281","author":"Alahgholi-Hajibehzad","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/acn3.51","article-title":"VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis","volume":"1","author":"Avidan","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1212\/NXI.0000000000000450","article-title":"Thymectomy lowers the myasthenia gravis biomarker miR-150-5p","volume":"5","author":"Molin","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI81894","article-title":"Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases","volume":"126","author":"Dragin","year":"2016","journal-title":"J Clin Invest."},{"key":"B38","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt Sinai J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/0002-9378(71)90951-3","article-title":"The relation of serum 17-hydroxyprogesterone and estradiol-17-beta levels during the human menstrual cycle","volume":"111","author":"Thorneycroft","year":"1971","journal-title":"Am J Obstet Gynecol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T09:49:31Z","timestamp":1582278571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2020.00151"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00151","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"article-number":"151"}}